It is increasingly apparent that the differences in the prevalence and severity of various gynaecological conditions are a function of immunosuppression and differences in behavioural factors, rather than a direct effect of HIV itself. Women infected with HIV will present with their gynaecological disorders initially to their carers in both primary care and genitourinary medicine clinic settings. It is therefore essential that all those involved in the management of these women are aware of the interactions between HIV infection, immunosuppression and various gynaecological conditions so that they may be appropriately managed.
SchaferAFriedmannWMielkeMThe increased frequency of cervical dysplasia and neoplasia in women infected with HIV is related to the degree of immunosuppression. Am J Obstet Gynecol1991;164:593–9.
2.
AgarossiAMuggiascaMRavasiLHIV infection and CIN. VIIIth International Conference on AIDS, 1992, Abstract 3045.
3.
SmithJRKitchenVSBothcherbyMIs HIV infection associated with an increase in the prevalence of cervical neoplasia. Br J Obstet Gynaecol1993;100:149–53.
4.
Centers for Disease Control. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR1993;41:1–19.
5.
BartonSMaddoxPSmithJA study of Langerhans cells in the cervical epithelium of women with HIV infection. VI International Conference on AIDS, Abstract 2103.
6.
ContiMAgarossiAMuggiascaMHigh rate of progression of cervical HPV and CIN in HIV infected women. VIII International Conference on AIDS, 1992, Abstract 3050.
7.
PiotPLagaM.Genital ulcers, other sexually transmitted diseases, and the sexual transmission of HIV. BMJ1989;298:623–4.
8.
RhoadsJLWrightDCRedfieldRRChronic vaginal candidiasis in women with HIV infection. JAMA1987;257(22):3105–7.
9.
KellPDBartonSEHawkinsDAThe clinical presentation of women with HIV infection. Br J Obstet Gynaecol1991;98:103–4.
10.
ShahPNBartonSE.Cytomegalovirus infection leading to vaginal ulceration in a woman with AIDS. Int J STD & AIDS1993;4:346–7.
11.
MinkoffMLDeHovitzJA.Care of women infected with the human immunodeficiency virus. JAMA1991;266:2253–8.
12.
HoegsburgBAbylafiaOSedlisASexually transmitted diseases and HIV infection among women with pelvic inflammatory disease. Am J Obstet Gynecol1990;163:1135–9.
13.
KloserPGrigoriuAKapilaR.Women with AIDS: a continuing study. Vth International Conference on AIDS, 1989, Abstract 4067.
14.
WaghU MathurRocheNSteinJGynaecological findings in an HIV positive outpatient population: an update. VIIIth International Conference on AIDS, 1992, Abstract 3058.
15.
WarnePAEhrhardtASchechterDMenstrual abnormalities in HIV positive and negative women with a history of intravenous drug use. VIIth International Conference on AIDS, 1991, Abstract 3113.
16.
ShahPNSmithJRWellsCMenstrual symptoms in women infected by HIV. Obstet Gynecol1994;83:397–40.
17.
ChirgwinKDeHovitzJAKellyPLack of association between CD4 count and menstrual abnormalities. IXth International Conference on AIDS, 1993, Abstract 1948.
18.
DobsADempseyNLadensonPEndocrine disorders in men infected with HIV. Am J Med1988;84:611–6.
19.
ShahPNSmithJRWellsCEndocrine function in HIV seropositive women. IX International Conference on AIDS, 1993, Abstract 1964.
20.
RyderRWBatterVLNsuamiMFertility rates in 238 HIV-1-seropositive women in Zaire followed for 3 years postpartum. AIDS1991;5(12):1521–7.
21.
SempriniAESettiPLBozzoMInsemination of HIV-negative women with processed semen of HIV-positive partners. Lancet1992;340:1317–9.
22.
SmithJRForsterGEKitchenVSInfertility management in HIV seropositive couples: A dilemma. BMJ1991;302:1447–50.
23.
MiotiPGDallabettaGNdoviEHIV 1 and pregnant women: Associated factors, prevalence, estimate of incidence and role in fetal wastage in central Africa. AIDS1990;4:733–6.
24.
BrettleRLeenC.The natural history of HIV and AIDS in women. AIDS1991;5:1282–92.
25.
FotherbyKHamawiW.Immunological aspects of contraceptive steroids. J Obstet Gynecol1984;Suppl 1:57–61.
